CN1582753A - 一种牦牛骨髓粉保健品及其制备方法 - Google Patents
一种牦牛骨髓粉保健品及其制备方法 Download PDFInfo
- Publication number
- CN1582753A CN1582753A CNA2004100427535A CN200410042753A CN1582753A CN 1582753 A CN1582753 A CN 1582753A CN A2004100427535 A CNA2004100427535 A CN A2004100427535A CN 200410042753 A CN200410042753 A CN 200410042753A CN 1582753 A CN1582753 A CN 1582753A
- Authority
- CN
- China
- Prior art keywords
- parts
- bovis grunniens
- medulla bovis
- poria
- semen nelumbinis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims description 32
- 230000036541 health Effects 0.000 title claims description 28
- 238000000034 method Methods 0.000 title claims description 4
- 239000000284 extract Substances 0.000 claims abstract description 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims description 29
- 210000000582 semen Anatomy 0.000 claims description 18
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 16
- 210000000988 bone and bone Anatomy 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 8
- 239000007901 soft capsule Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 210000002745 epiphysis Anatomy 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 230000001788 irregular Effects 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 abstract description 7
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000021388 linseed oil Nutrition 0.000 abstract 1
- 239000000944 linseed oil Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 9
- 239000011575 calcium Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 208000001132 Osteoporosis Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 231100000456 subacute toxicity Toxicity 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 108010071619 Apolipoproteins Proteins 0.000 description 2
- 102000007592 Apolipoproteins Human genes 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 101710095342 Apolipoprotein B Proteins 0.000 description 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000019680 high-energy food Nutrition 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
组别 | 剂量(g/kg) | Ca(%) | P(%) |
对照组 | - | 22.59±0.44 | 9.21±0.19 |
模型组 | - | 18.44±1.26*** | 7.59±1.00*** |
试验组 | 1.25 | 21.62±0.98ΔΔΔ | 9.11±0.36ΔΔ |
2.5 | 22.18±0.92ΔΔΔ | 9.16±0.30ΔΔΔ | |
5.0 | 22.20±0.75ΔΔΔ | 9.45±0.33ΔΔΔ |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100427535A CN1319471C (zh) | 2004-05-26 | 2004-05-26 | 一种牦牛骨髓粉保健品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100427535A CN1319471C (zh) | 2004-05-26 | 2004-05-26 | 一种牦牛骨髓粉保健品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1582753A true CN1582753A (zh) | 2005-02-23 |
CN1319471C CN1319471C (zh) | 2007-06-06 |
Family
ID=34601663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100427535A Expired - Fee Related CN1319471C (zh) | 2004-05-26 | 2004-05-26 | 一种牦牛骨髓粉保健品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1319471C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657332A (zh) * | 2012-05-08 | 2012-09-12 | 祁宝红 | 一次性连续生产牦牛骨髓油和超微多肽骨钙粉的制备方法 |
CN103719868A (zh) * | 2013-06-27 | 2014-04-16 | 广州维思贝生物科技有限公司 | 富含ω-3多不饱和脂肪酸的早餐营养粉及其制备方法 |
CN103750330A (zh) * | 2014-02-18 | 2014-04-30 | 安国市金木生物科技有限公司 | 一种含有牛骨髓粉的口服组合物及其制备方法 |
CN105166957A (zh) * | 2015-07-30 | 2015-12-23 | 王之宝 | 一种牛肉骨髓粉的制作工艺及应用 |
CN108185407A (zh) * | 2017-12-28 | 2018-06-22 | 王清秀 | 促进灵芝粉吸收利用率的方法以及得到的灵芝羊骨髓肽粉组合物和应用 |
CN114946975A (zh) * | 2022-04-12 | 2022-08-30 | 王连声 | 一种含有牦牛骨髓粉的养生茶及其制作工艺 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1063031C (zh) * | 1998-08-11 | 2001-03-14 | 北京长寿保健品有限公司 | 一种延缓衰老的营养保健品及其制造方法 |
CN1259384A (zh) * | 1999-01-06 | 2000-07-12 | 哈尔滨红太阳实业有限公司 | 牦牛骨髓壮骨粉及其加工方法 |
CN1244425A (zh) * | 1999-07-30 | 2000-02-16 | 冶明忠 | 一种牦牛骨髓粉保健食品及其制造方法 |
CN1313091A (zh) * | 2000-03-13 | 2001-09-19 | 哈尔滨红太阳保健品有限公司 | 彼阳牦牛骨髓壮骨胶囊 |
CN1356115A (zh) * | 2001-01-11 | 2002-07-03 | 李方瑞 | 一种虫草牦牛壮骨冲剂 |
CN1231146C (zh) * | 2001-04-08 | 2005-12-14 | 内蒙古草原兴发股份有限公司 | 多肽骨粉的生产方法 |
CN1146667C (zh) * | 2001-05-24 | 2004-04-21 | 谢启安 | 动物骨及组织提取骨髓氨基酸多肽生产工艺 |
-
2004
- 2004-05-26 CN CNB2004100427535A patent/CN1319471C/zh not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657332A (zh) * | 2012-05-08 | 2012-09-12 | 祁宝红 | 一次性连续生产牦牛骨髓油和超微多肽骨钙粉的制备方法 |
CN103719868A (zh) * | 2013-06-27 | 2014-04-16 | 广州维思贝生物科技有限公司 | 富含ω-3多不饱和脂肪酸的早餐营养粉及其制备方法 |
CN103750330A (zh) * | 2014-02-18 | 2014-04-30 | 安国市金木生物科技有限公司 | 一种含有牛骨髓粉的口服组合物及其制备方法 |
CN103750330B (zh) * | 2014-02-18 | 2015-02-25 | 安国同源堂生物科技有限公司 | 一种含有牛骨髓粉的口服组合物及其制备方法 |
CN105166957A (zh) * | 2015-07-30 | 2015-12-23 | 王之宝 | 一种牛肉骨髓粉的制作工艺及应用 |
CN108185407A (zh) * | 2017-12-28 | 2018-06-22 | 王清秀 | 促进灵芝粉吸收利用率的方法以及得到的灵芝羊骨髓肽粉组合物和应用 |
CN114946975A (zh) * | 2022-04-12 | 2022-08-30 | 王连声 | 一种含有牦牛骨髓粉的养生茶及其制作工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN1319471C (zh) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2019516412A (ja) | 低分子コラーゲンペプチドおよびこれを用いた食品組成物の製造方法 | |
KR101467539B1 (ko) | 삼채분말이 함유된 가금류용 사료 조성물의 제조방법 | |
CN1319471C (zh) | 一种牦牛骨髓粉保健品及其制备方法 | |
CN109170916A (zh) | 一种强身健体食品组合物及其制备方法 | |
CN1802943A (zh) | 一种微米花果山金猴子糖消食益胃酸奶制备方法 | |
CN100350846C (zh) | 一种微米糖参马桃花鹿补肾消疲酸奶制备方法 | |
CN1784997A (zh) | 一种复方微米松花魔芋露减肥降糖酸奶制备方法 | |
CN1806574A (zh) | 一种微米灰树三花灵芝孢抗肿瘤突变酸奶制备方法 | |
CN109805235A (zh) | 一种降四高的麦香复合多肽固体饮料、制备方法及用途 | |
CN100387138C (zh) | 一种复方微米太子参降糖补钙奶粉制备方法 | |
CN1806576B (zh) | 一种微米鹿茸红花仙子补肾消疲酸奶制备方法 | |
CN100381066C (zh) | 一种微米鹿龙松花精壮骨益肾消疲奶粉制备方法 | |
CN100518524C (zh) | 一种微米鹿龙松花精壮骨益肾消疲奶片制备方法 | |
CN100518523C (zh) | 一种微米金山仙人糖太子健脾消食酸奶制备方法 | |
CN100370909C (zh) | 一种微米松花鹿胎女耳红温肾养颜奶粉制备方法 | |
CN100475046C (zh) | 一种微米金苡白药松花粉消食健脾奶粉制备方法 | |
CN1748520A (zh) | 一种微米糖参四肾桃花壮阳消疲酸豆奶制备方法 | |
CN1748526A (zh) | 一种复方微米太子参降糖补钙奶液制备方法 | |
CN1802956A (zh) | 一种微米鹿茸红花仙子补肾消疲奶液制备方法 | |
CN1748518A (zh) | 一种复方微米太子参降糖补钙酸豆奶制备方法 | |
CN1806602A (zh) | 一种微米鹿龙松花精壮骨益肾消疲奶液制备方法 | |
CN1806580A (zh) | 一种微米鹿龙松花精壮骨益肾消疲酸奶制备方法 | |
CN1692758A (zh) | 一种微米糖参银耳养颜润肺降糖酸乳制备方法 | |
CN1788588A (zh) | 一种微米灰树三花灵芝孢抗肿瘤突变奶液制备方法 | |
CN1748521A (zh) | 一种微米糖参四肾桃花壮阳消疲酸奶制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LV YONGLI Free format text: FORMER OWNER: CAOYUANXINGFA CO., LTD., NEIMONGGOL AUTONOMOUS REGION Effective date: 20080104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080104 Address after: Room 11, building 331, Xiangyang District, Ping Zhen Town, Yuanbaoshan District, the Inner Mongolia Autonomous Region, Chifeng Patentee after: Lv Yongli Address before: The Inner Mongolia Autonomous Region Chifeng City Yuanbaoshan District Economic Development Zone Building of Caoyuanxingfa Patentee before: Caoyuan-Xingfa Co., Ltd., Inner Mongolian Autonomous Region |
|
CI01 | Correction of invention patent gazette |
Correction item: Address of the patentee Correct: Room 11, building 331, Xiangyang District, Ping Zhen Town, Yuanbaoshan District, the Inner Mongolia Autonomous Region, Chifeng False: 331, building 11, Xiangyang District, Ping Town, Yuanbaoshan District, the Inner Mongolia Autonomous Region, Chifeng Number: 6 Page: 1316 Volume: 24 |
|
ERR | Gazette correction |
Free format text: CORRECT: PATENTEE ADDRESS; FROM: 331, BUILDING 11, XIANGYANG RESIDENTIAL QUATER, PINGZHUANG TOWN, YUANBAOSHAN DISTRICT, CHIFENG CITY, INNER MONGOLIA AUTONOMOUS REGION TO: ROOM 331, BUILDING 11, XIANGYANG RESIDENTIAL QUATER, PINGZHUANG TOWN, YUANBAOSHAN DISTRICT, CHIFENG CITY, INNER MONGOLIA AUTONOMOUS REGION |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |